CCORF Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $366
TD Cowen Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Raises Target Price to $371
TD Cowen Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)
H.C. Wainwright Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $400
Alnylam Pharmaceuticals Analyst Ratings
Scotiabank Initiates Alnylam Pharmaceuticals at Sector Outperform With $305 Price Target
BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Raises Target Price to $314
Alnylam Pharmaceuticals Is Maintained at Buy by Chardan Capital
Cantor Fitzgerald Reiterates Neutral on Alnylam Pharmaceuticals, Maintains $220 Price Target
A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $282 to $370
A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $275 to $342
Alnylam Pharmaceuticals Price Target Maintained With a $320.00/Share by Needham
Alnylam Pharmaceuticals Analyst Ratings
Balancing Promise and Caution: A Hold Rating for Alnylam Pharmaceuticals Amid Evolving Market Dynamics
A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $282 to $370
TD Cowen Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $282
Piper Sandler Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Raises Target Price to $296
Alnylam Pharma (ALNY) Receives a Buy From TD Cowen
Morgan Stanley Maintains Alnylam Pharmaceuticals(ALNY.US) With Hold Rating, Maintains Target Price $275
BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $307